Multiple sclerosis trials recruiting in Oklahoma

All Multiple sclerosis trials nationally

Cities in Oklahoma

Recruiting trials in Oklahoma

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
  NCT06433752 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Oklahoma: Norman
• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
  NCT07299019 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
  NCT06735248 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
  NCT05285891 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Skeletal Muscle Aging and Responsiveness in Aged People With MS
  NCT07500727 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · Oklahoma: Oklahoma City
• Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
  NCT05877963 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Oklahoma: Oklahoma City